NEW YORK -- BrainPOP, a leading producer of animated educational movies for kids, announces a new health movie about SARS.
Over the past two weeks, BrainPOP's Q&A email service has received many questions from 8-14 year-olds about SARS, asking questions like, "Can I get SARS at school?" and "Is it safe to eat Chinese food?" Kids hear a lot about what's going on in the world, both from media sources and their peers. With SARS as a constant presence in the daily news, BrainPOP felt that it was important to cover SARS using a familiar format that spoke just to kids -- an animated BrainPOP movie.
The SARS movie presents the facts about Severe Acute Respiratory Syndrome without causing undue fear. BrainPOP characters, Tim and Moby, uncover the coronavirus, discuss how it can be passed from one person to another, and chart SARS' movement around the globe. Tim and Moby acknowledge global fears about the severity of SARS, while putting things in perspective -- at this early time, there is much that is unknown about SARS.
BrainPOP CEO, Avraham Kadar, MD, commented on the need for a SARS movie geared towards kids and teens. "Most SARS information is presented for an adult audience. From the questions our characters have been receiving, we know that kids are aware of SARS and that they are concerned. The SARS movie is really a straight-forward explanation of what we know of SARS origin and behavior, in simple terms, along with some humor and reassurance from the BrainPOP characters."
BrainPOP is showcasing its SARS movie at www.BrainPOP.com.
BrainPOP is a leading producer of animated educational movies for K-12. Each month 2 million kids watch BrainPOP movies and exchange messages with a dynamic cast of five characters who lead the user through related activities -- interactive quizzes and games, comic strips and experiments. Ten percent of U.S. school districts subscribe to BrainPOP and integrate it into their lessons.
Source: BrainPOP
Ensuring Safety and Comfort: The Urgent Need for Well-Fitted PPE in Health Care
April 5th 2024Personal protective equipment (PPE) stands as the first line of defense against infectious diseases in health care. Yet, the issue of ill-fitting PPE, especially for women, remains a significant challenge.
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.